Indian Journal of Pathology and Microbiology

BRIEF COMMUNICATION
Year
: 2018  |  Volume : 61  |  Issue : 2  |  Page : 225--227

Expression of E-cadherin, syndecan 1, Ki-67, and maintenance minichromosome 3 in tissue lesions of actinic prurigo obtained by incisional biopsy


Alexandra Mancheno-Valencia1, Ronell Eduardo Bologna-Molina2, Sonia Toussaint-Caire1, María Elisa Vega-Memije1, Juan Carlos Cuevas-González3,  
1 Department of Dermatology, “Dr. Manuel Gea González” General Hospital, Mexico City, Mexico
2 Faculty of Dentistry, University of the Republic, Montevideo, Uruguay
3 Department of Stomatology, Institute of Biomedical Sciences, Autonomous University of Ciudad Juarez, Chihuahua, Mexico

Correspondence Address:
María Elisa Vega-Memije
Department of Dermatology, “Dr. Manuel Gea González” General Hospital, Calzada De Tlalpan 4800, Sección XVI, Delegación Tlalpan México, D.F. C.P 14080
Mexico

Abstract

Actinic prurigo (AP) is an idiopathic photodermatosis; the initial manifestations usually occur during the first decades of life but can appear at any age. Cases are usually diagnosed late once the lesions have exacerbated; due to the extensive involvement of the vermilion border and the etiology, it has been confused with and related to a potentially malignant process. Syndecan-1 and E-cadherin were positive in the epidermis, with moderate-to-intense staining in 100% of samples. Ki67 and MCM3 were expressed in the lower third of the epidermis and showed greater immunolabeling in samples that contained lymphoid follicles (Ki 67: epidermis [17.7% ± 6.79%] and dermis [7.73% ± 6.69%]; MCM3: epidermis [22.92% ± 10.12%] and dermis [6.13% ± 6.27%]). In conclusión AP is a disease in which there is no evidence that the lesions are potentially cancerous. AP cheilitis should not be confused with actinic cheilitis because they are separate entities.



How to cite this article:
Mancheno-Valencia A, Bologna-Molina RE, Toussaint-Caire S, Vega-Memije ME, Cuevas-González JC. Expression of E-cadherin, syndecan 1, Ki-67, and maintenance minichromosome 3 in tissue lesions of actinic prurigo obtained by incisional biopsy.Indian J Pathol Microbiol 2018;61:225-227


How to cite this URL:
Mancheno-Valencia A, Bologna-Molina RE, Toussaint-Caire S, Vega-Memije ME, Cuevas-González JC. Expression of E-cadherin, syndecan 1, Ki-67, and maintenance minichromosome 3 in tissue lesions of actinic prurigo obtained by incisional biopsy. Indian J Pathol Microbiol [serial online] 2018 [cited 2020 May 26 ];61:225-227
Available from: http://www.ijpmonline.org/text.asp?2018/61/2/225/230560


Full Text



 Introduction



Actinic prurigo (AP) is an idiopathic photodermatosis that affects the skin and labial and conjunctival mucosa. Miscegenation is a significant racial factor that is linked to human leukocyte antigen (HLA), particularly the HLA-DR4 allele, which varies between populations. In Mexico, 90%–92.8% of patients with AP have this allele (HLA-DRB1*0407 is the most frequent subtype [60%–80%]).[1],[2],[3]

The initial manifestations of AP usually occur during the first decades of life but can appear at any age. Cases are usually diagnosed late once the lesions have exacerbated, AP preferentially affects women at a 2:1 ratio and persons with dark phototypes (Fitzpatrick IV and V classification).[4],[5],[6],[7]

The lesions develop after sun exposure, usually as papules, macules, excoriations, serohematous scabs, areas of lichenification, scars, hypo- or residual hyperpigmentation, edema, cracks, fissures, and ulcers on the vermilion border lip. These signs constitute AP cheilitis, which has an acute phase with exudative lesions and adherent yellow scabs and a chronic phase, in which there is scaling and xerosis.[8] Due to the extensive involvement of the vermilion border and the etiology that is associated with sun exposure, it has been confused with and related to a potentially malignant process.

Common histopathological features of AP are hyperkeratosis, parakeratosis, acanthosis, thickening of the basement membrane, perivascular inflammatory, lymphoid follicles, or nodular lymphocytic infiltrate, as well as eosinophils, mast cells, and angiogenesis.[9]

Syndecan 1 is a cell surface proteoglycan and is an active component of the molecular adhesion between cells and the extracellular matrix; its loss of expression is associated with malignant transformation and is directly related to the advanced stages of the neoplasia. Cadherins mediate the adhesion between cells.

Maintenance minichromosomes (MCMs) are a family of eight proteins – MCM2-MCM-7 and MCM-10 – which regulate the S phase of the cell cycle.[10] MCM3 and Ki67 are important markers of cell proliferation. Thus, the expression of these markers was examined to increase our understanding of the pathophysiology of AP and demonstrate that this disease does not have malignant potential.

 Materials and Methods



This descriptive study included paraffin-embedded tissues (from lip and skin incisional biopsy) in patients with a confirmed diagnosis of AP (n = 24). Two dermatopathologists who were experts in this area assessed all cases. Hematoxylin and eosin staining was used to analyze the histopathological characteristics of the samples, obtained from the patient. Sociodemographic data, such as age, sex, and biopsy site, were collected.

Two micron sections were performed and stained by immunohistochemistry (monoclonal primary antibodies: Dako syndecan-1 (CD-138), clone: Ml15, 1:100 dilution; Dako E-cadherin, clone: NCH-38, 1:100 Ki-67, Dako, clone: MIB 1, 1:50 dilution; and MCM3, Abcam Cambridge UK, clone: ab97282, 1:100 dilution were used); the tissues were counterstained with Mayer's hematoxylin.

Expression was evaluated semi-quantitatively in five fields per case at ×400 [Table 1] and was photographed with an Olympus C-7070 digital camera.{Table 1}

 Results



Of the 24 cases in the study, n = 12, 50% were female patients, and all were diagnosed with AP. The mean evolution of the disease was 11.25 years, and the most frequent biopsy site was the lip n = 20, 83.3% and skin n = 4, 16.6%.

Syndecan-1 and E-cadherin were positive in the epidermis, with moderate-to-intense staining in 100% of samples. Syndecan-1 was expressed in the dermis in 25% of cases due to the presence of plasma cells; E-cadherin was negative at this site [Table 2].{Table 2}

Ki67 and MCM3 were expressed in the lower third of the epidermis, and in the dermis, these markers showed greater immunolabeling in samples that contained lymphoid follicles (Ki 67: epidermis [17.7% ± 6.79%] and dermis [7.73% ± 6.69%]; MCM3: epidermis [22.92% ± 10.12%] and dermis [6.13% ± 6.27%]). [Figure 1] and [Table 3] show the immunohistochemistry results by sex and location.{Figure 1}{Table 3}

 Discussion



AP is a condition that is diagnosed late. In a study at General Hospital Dr. Manuel Gea González, where the sociodemographic profiles of such patients have been reported for the past 20 years, the average time of making the diagnosis was 8.78 years after the initial lesions had appeared [2] versus 11.25 years in the current study. Thus, if the diagnosis is established in a timely manner, it is possible to avoid the appearance of its clinical characteristics, before they exacerbate in the chronic phase.

Fifty percent of our cohort was male, which might be due to the small sample. Furthermore, 83.3% of biopsies were taken from the lip, which is consistent with it being the preferred site for histopathological studies.

MCM is a cell cycle regulator; they are expressed at high levels during proliferation and degrade in the resting state and senescence and are thus used as markers of cell proliferation.[10] MCMs are also positive in cells without alteration (located in the basal stratum) that are in the normal phase of proliferation but at lower levels compared with neoplastic cells, which serve as a reference during the evaluation.[11] Our results are consistent with the literature; MCM-3 positivity was observed in the lower third of the epidermis and in the dermis in cases that had lymphoid follicles.

Ki-67 is a nuclear protein that is present in all active phases of the cell cycle, except G0 and quiescence, and is used to measure the fraction of healthy and neoplastic tissues that is growing.[12] Arrese et al. studied the histopathology of 20 Mexican miscegenated patients who were diagnosed with AP using immunohistochemical panels and observed that Ki-67 was positive in 34.5% of epidermal cells and in the strata basale and spinosum.[6] We also noted positivity of Ki-67 in the basal stratum in 17.7% of cases. Thus, based on MCM-3 and Ki-67 immunolabeling, cell proliferation is not increased in this disease.

Cadherins are a family of transmembrane type 1 proteins that mediate Ca 2+-dependent cell–cell adhesion in epithelial tissues maintain cell polarity and adhesion in tissues. Its epithelial expression decreases in potentially cancerous lesions.[13] Syndecan members form a family of cell surface proteoglycans that interact with several molecular effectors of the extracellular matrix and growth factors. Syndecan-1 is found primarily in epithelial cells and mediates cell adhesion with various molecules of the extracellular matrix.[14] In our AP tissues, syndecan-1 and E-cadherin were positive throughout the epidermal thickness in 100% of cases, confirming that there is no loss of cell adhesion in this disease and thus suggesting a malignant process.

 Conclusions



AP is a disease in which there is no evidence that the lesions are potentially cancerous. AP cheilitis should not be confused with actinic cheilitis because they are separate entities with regard to their clinical and histopathological characteristics and their potential for malignancy.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

1Vera Izaguirre DS, Zuloaga Salcedo S, González Sánchez PC, Sánchez Lara K, Chávez Tapia N, Hojyo Tomoka MT, et al. Actinic prurigo: A case-control study of risk factors. Int J Dermatol 2014; 53:1080-5.
2Cuevas-González JC, Rodríguez-Lobato E, Mancheno-Valencia A, Hojyo-Tomoka MT, Domínguez-Soto L, Vega-Memije ME. Actinic Prurigo; demographic profile of the last 20 years in the dermatology division of the general hospital Dr. Manuel Gea González in Mexico City. Dermatol Rev Mex 2014; 58:508-13.
3Granados-Arriola J, Domínguez-Soto L. Immunogenetics of actinic prurigo in Mexican patients. Dermatol Rev Mex 1993;37:314-5.
4Hojyo-Tomoka MT, Vega-Memije ME, Cortes-Franco R, Domínguez-Soto L. Diagnosis and treatment of actinic prurigo. Dermatol Ther 2003;16:40-4.
5Hojyo-Tomoka T, Vega-Memije E, Granados J, Flores O, Cortés-Franco R, Teixeira F, et al. Actinic prurigo: An update. Int J Dermatol 1995;34:380-4.
6Arrese JE, Dominguez-Soto L, Hojyo-Tomoka MT, Vega-Memije E, Cortés-Franco R, Guevara E, et al. Effectors of inflammation in actinic prurigo. J Am Acad Dermatol 2001;44:957-61.
7Sachdeva S. Fitzpatrick skin typing: Applications in dermatology. Indian J Dermatol Venereol Leprol 2009;75:93-6.
8Díaz-Lozano M, Toussaint-Caire S, Vega-Memije ME, Mosqueda-Taylor A, Cuevas-González JC, Rodríguez-Lobato E, et al. Histopathological patterns in cheilitis of actinic prurigo. Patologia 2016;54:59-65.
9Vega ME. Histopathological characteristics of actinic prurigo. Dermatol Rev Mex 1993;37:295-7.
10Hua C, Zhao G, Li Y, Bie L. Minichromosome maintenance (MCM) family as potential diagnostic and prognostic tumor markers for human gliomas. BMC Cancer 2014;14:526.
11Ha SA, Shin SM, Namkoong H, Lee H, Cho GW, Hur SY, et al. Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis. Clin Cancer Res 2004;10:8386-95.
12Cuevas-González MV, Vega-Memije ME, Cuevas-González JC, García-Vazquez FJ, Chairez-Atienzo P, Avila-Valdez R. Expression of CD34, Ki-67, p53 and cytokeratin AE1/AE3 in solid and adenoid basal cell carcinoma. Dermatol Rev Mex 2016;60:311-8.
13Cháirez-Atienzo P, Vega-Memije ME, García-Vázquez FJ, Cuevas-González JC. Expression of E-cadherin and Langerhans cells in common warts and oral papillomas. Rev ADM 2016;73:291-6.
14Carreón-Burciaga RG, Mendoza-Roaf P, Amezcua-Rosas G, Bologna-Molina R, Gonzélez-Montemayor T, Gonzalez-Gonzalez R, et al. Expression of E-cadherin and syndecan-1 in lichen planus of skin and oral mucosa. Int J Odontostomatol 2014;8:439-45.